Skip to main content
. 2021 May 16;6(8):1–8. doi: 10.1001/jamacardio.2021.1157

Table 2. Biochemical Measurements 12 Months After Randomization by Tertile of Plasma EPA Level.

Variable Median (IQR)
All patients (n = 10 382) Corn oil (n = 5207) All EPA (n = 5175) Plasma EPA
Tertile 1 (n = 1733) Tertile 2 (n = 1727) Tertile 3 (n = 1715)
Laboratory data
Cholesterol, mg/dL
Total 158 (134-189) 162 (138-192) 154 (131-185) 158 (131-197) 144 (125-170) 161 (141-192)
LDL 76 (56-101) 75 (55-100) 76 (57-103) 76 (56-110) 71 (52-91) 82 (63-107)
HDL 37 (32-43) 37 (32-42) 37 (32-43) 37 (32-43) 37 (32-42) 38 (33-43)
Triglyceride, mg/dL 212 (159-288) 235 (178-315) 191 (145-255) 198 (146-270) 177 (139-228) 198 (153-271)
Non-HDL cholesterol, mg/dL 120 (97-150) 124 (101-152) 116 (94-146) 119 (94-156) 107 (88-132) 123 (102-153)
Apolipoprotein B, mg/dL 56 (44-70) 56 (45-70) 55 (44-70) 56 (44-71) 52 (42-66) 57 (47-74)
Apolipoprotein C-III, mg/dL 17 (13-21) 18 (14-23) 16 (13-20) 16 (12-20) 15 (12-19) 17 (13-21)
hs-CRP, mg/dLa 0.18 (0.09-0.38) 0.18 (0.09-0.40) 0.17 (0.08-0.37) 0.18 (0.09-0.40) 0.18 (0.09-0.38) 0.15 (0.08-0.32)
Plasma EPA, ug/mL 35 (16-92) 19 (12-31) 89 (46-131) 30 (17-47) 90 (76-103) 151 (132-181)
RBC EPA, % of total 1.0 (0.5-2.8) 0.6 (0.4-0.9) 2.8 (1.5-4.0) 1.0 (0.6-1.7) 2.9 (2.4-3.6) 4.3 (3.5-5.1)
Plasma DHA, ug/mL 75 (53-101) 58 (44-80) 91 (71-114) 67 (53-84) 88 (76-103) 118 (102-143)
RBC DHA, % of total 5.8 (4.5-6.8) 4.8 (3.8-6.0) 6.6 (5.7-7.3) 5.7 (4.7-6.5) 6.6 (6.1-7.3) 7.1 (6.4-7.8)

Abbreviations: DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; HDL, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; IQR, interquartile range; LDL, low-density lipoprotein cholesterol; RBC, red blood cell.

SI conversion factor: To convert apolipoprotein to grams per liter, multiply by 0.01; cholesterol levels to millimoles per liter, multiply by 0.0259; hs-CRP to milligrams per liter, multiply by 10; triglycerides to millimoles per liter, multiply by 0.0113.

a

All follow-up measures were at 12 months, except for hs-CRP, which was measured at 60 months (n = 1390 in corn oil placebo and n = 1372 in ω-3 CA).